Glenmark Pharmaceuticals Ltd. Industry : (Pharmaceuticals)

Quick Glance
Listed on BSE and NSE
  • Market Cap 18,804Crores
  • Book Value 183
  • Face Value 1
  • Current Price 666.40
  • % Change -1.57
  • 52 week H/L 712/ 484
  • Stock P/E 23.39
  • Dividend Yield 0 %

Stock vs. Index

GlenmarkPhar
Sensex

Historical Return

1 Yr (%) 2 Yr (%) 3 Yr (%) 4 Yr (%) 5 Yr (%)
24.93 -26.61 -22.12 -17.43 27.55

ROCE Vs RONW

ROCE
RONW

Price History


  • Start Date :
  • End Date :

You can view historic prices (Open,High,Low,Close) of the company for the range of days


Shareholding Pattern

collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Dec 16 Mar 17 Jun 17 Sep 17 Dec 17 Mar 18 Jun 18 Sep 18
Sales 2191.78 2065.09 1547.78 1659.81 1556.55 1667.75 1618.41 1679.72
Other Income 106.36 -50.25 42.59 56.30 37.23 44.30 173.65 226.30
Operating Profit 844.41 672.10 352.94 397.46 266.80 330.31 410.30 391.81
Interest 49.54 49.72 45.74 47.44 47.00 50.72 55.17 60.85
Depreciation 26.34 27.32 29.94 28.89 29.55 29.82 33.42 26.92
Taxation 163.58 -48.70 49.01 49.55 33.36 72.56 97.97 172.95
Net Profit / Loss 711.31 357.06 270.84 327.88 194.12 221.51 397.39 747.56

Annual Results

(All figures In Rs. Cr.) Mar 10 Mar 11 Mar 12 Mar 13 Mar 14 Mar 15 Mar 16 Mar 17 Mar 18
Sales 1022.78 1154.63 1564.67 1949.30 2300.90 5085.60 6203.08 8095.50 6431.88
Other Income 8.32 30.39 55.10 116.25 67.13 84.94 117.38 148.24 180.42
Operating Profit 164.13 277.49 310.98 332.44 495.97 1464.99 1765.18 2898.64 1347.51
Interest 30.16 36.08 60.87 43.69 30.98 30.19 36.22 152.60 190.90
Depreciation 21.28 20.99 21.11 25.04 30.20 119.46 99.81 104.93 118.20
Taxation -7.45 38.63 18.80 -6.15 68.10 224.02 262.26 412.29 204.48
Net Profit / Loss 128.46 212.18 265.30 386.11 433.82 1007.53 1484.27 2140.61 1014.35

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM 14.44% 6.83%
1 Years -15.28% -11.00%
2 Years -38.09% -38.09%
3 Years -32.01% -36.16%
4 Years -29.95% -34.83%
5 Years -21.24% -17.57%

Investor Returns

Type Ratio / % Date
Dividend
200.00
19 Sep 2018
Bonus
1:1
04 Mar 2005
Split
2:1
10 Sep 2007

Announcements

Date Title
Nov 29, 2018 Glenmark Pharma - Registrar & Share Transfer Agent Update
Nov 29, 2018 Glenmark Pharma - Transfer Of Operations Of Registrar And Share Transfer Agent
Nov 26, 2018 Glenmark Pharma - Press Release
Nov 26, 2018 Glenmark bags tentative USFDA approval for Clobetasol Propionate Foam
Nov 22, 2018 Glenmark receives USFDA approval for Atovaquone Oral Suspension USP
collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
419.75
-0.57%
100,711.80
678.80 / 391.10
158.80
46.59
Dr. Reddy's Laboratories Ltd.
2,591.60
-0.17%
43,032.44
2,745.00 / 1,888.00
757.12
45.45
Aurobindo Pharma Ltd.
726.80
-3.11%
42,583.77
830.00 / 527.05
199.36
17.57
Cipla Ltd.
521.40
-1.20%
42,007.58
678.00 / 503.95
176.61
29.78
Divi's Laboratories Ltd.
1,492.40
-1.62%
39,618.53
1,577.00 / 978.50
223.18
45.17
Piramal Enterprises Ltd.
2,141.15
-1.51%
39,260.09
3,302.55 / 1,796.75
1,442.30
7.67
Biocon Ltd.
646.35
0.91%
38,781.00
718.35 / 508.00
86.33
104.14
Lupin Ltd.
842.80
-0.41%
38,117.00
986.00 / 723.55
300.20
151.71
Cadila Healthcare Ltd.
346.15
-0.97%
35,436.85
456.10 / 330.65
85.42
19.96
Torrent Pharmaceuticals Ltd.
1,783.90
-0.06%
30,187.64
1,871.95 / 1,223.75
273.14
44.52